4

OWNERSHIP DOCUMENT

Company: BioXcel Therapeutics, Inc.
Filed: January 27, 2021
Period of Report: January 25, 2021
Accession Number: 0001104659-21-008192

View Document ↗ View on SEC.gov ↗